AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,160,000 | +103.8% | 142,745 | -5.5% | 0.02% | +114.3% |
| Q4 2021 | $1,060,000 | -85.8% | 151,000 | -73.8% | 0.01% | -88.7% |
| Q1 2021 | $7,481,000 | -4.0% | 576,495 | 0.0% | 0.06% | 0.0% |
| Q4 2020 | $7,789,000 | +11.8% | 576,495 | -2.6% | 0.06% | -4.6% |
| Q3 2020 | $6,965,000 | -20.3% | 591,800 | 0.0% | 0.06% | -29.3% |
| Q2 2020 | $8,735,000 | -44.8% | 591,800 | -11.6% | 0.09% | -47.4% |
| Q1 2020 | $15,826,000 | -2.2% | 669,800 | 0.0% | 0.18% | +0.6% |
| Q4 2019 | $16,189,000 | +20.4% | 669,800 | -4.3% | 0.17% | -2.2% |
| Q3 2019 | $13,450,000 | -24.4% | 699,800 | +15.7% | 0.18% | -19.8% |
| Q2 2019 | $17,793,000 | -38.1% | 604,800 | 0.0% | 0.22% | -39.7% |
| Q1 2019 | $28,729,000 | +66.2% | 604,800 | +26.3% | 0.37% | +38.3% |
| Q4 2018 | $17,284,000 | -14.1% | 478,800 | +46.5% | 0.27% | -0.4% |
| Q3 2018 | $20,115,000 | +144.7% | 326,800 | +168.5% | 0.27% | +105.4% |
| Q2 2018 | $8,221,000 | +91.8% | 121,700 | +54.1% | 0.13% | +78.1% |
| Q1 2018 | $4,286,000 | -0.4% | 79,000 | +9.7% | 0.07% | -1.4% |
| Q4 2017 | $4,302,000 | +50.1% | 72,000 | +22.0% | 0.07% | +48.0% |
| Q3 2017 | $2,867,000 | +36.4% | 59,000 | +47.5% | 0.05% | +25.0% |
| Q2 2017 | $2,102,000 | +54.4% | 40,000 | +33.3% | 0.04% | +53.8% |
| Q1 2017 | $1,361,000 | +5.7% | 30,000 | -11.8% | 0.03% | -13.3% |
| Q4 2016 | $1,287,000 | +0.3% | 34,000 | 0.0% | 0.03% | -3.2% |
| Q3 2016 | $1,283,000 | -83.2% | 34,000 | -86.0% | 0.03% | -79.7% |
| Q1 2015 | $7,617,000 | -15.8% | 243,000 | -21.6% | 0.15% | -19.0% |
| Q4 2014 | $9,049,000 | – | 310,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |